GUADALUPE NAVARRO: Open Payments
NPI 1215683693 · PLAINFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$646 in 20 payments from 10 companies in 2025. Trend: 2023 $271 · 2024 $358 · 2025 $646
Food & beverage: $646
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $142 |
| Neurocrine BioSciences, Inc. | 4 | $132 |
| ARGENX US, INC. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| Janssen Pharmaceuticals, Inc | 2 | $33 |
| Lilly USA, LLC | 2 | $33 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: QULIPTA, INGREZZA, VYVGART HYTRULO, REXULTI, SPRAVATO, AUSTEDO XR, XIFAXAN, MOUNJARO.
Industry payments across IL — which companies pay providers there.
